549 related articles for article (PubMed ID: 17679663)
1. Guidelines for identification of, advocacy for, and intervention in neurocognitive problems in survivors of childhood cancer: a report from the Children's Oncology Group.
Nathan PC; Patel SK; Dilley K; Goldsby R; Harvey J; Jacobsen C; Kadan-Lottick N; McKinley K; Millham AK; Moore I; Okcu MF; Woodman CL; Brouwers P; Armstrong FD;
Arch Pediatr Adolesc Med; 2007 Aug; 161(8):798-806. PubMed ID: 17679663
[TBL] [Abstract][Full Text] [Related]
2. Bone mineral density deficits in survivors of childhood cancer: long-term follow-up guidelines and review of the literature.
Wasilewski-Masker K; Kaste SC; Hudson MM; Esiashvili N; Mattano LA; Meacham LR
Pediatrics; 2008 Mar; 121(3):e705-13. PubMed ID: 18310191
[TBL] [Abstract][Full Text] [Related]
3. Development of risk-based guidelines for pediatric cancer survivors: the Children's Oncology Group Long-Term Follow-Up Guidelines from the Children's Oncology Group Late Effects Committee and Nursing Discipline.
Landier W; Bhatia S; Eshelman DA; Forte KJ; Sweeney T; Hester AL; Darling J; Armstrong FD; Blatt J; Constine LS; Freeman CR; Friedman DL; Green DM; Marina N; Meadows AT; Neglia JP; Oeffinger KC; Robison LL; Ruccione KS; Sklar CA; Hudson MM
J Clin Oncol; 2004 Dec; 22(24):4979-90. PubMed ID: 15576413
[TBL] [Abstract][Full Text] [Related]
4. Screening for neurocognitive impairment in pediatric cancer long-term survivors.
Krull KR; Okcu MF; Potter B; Jain N; Dreyer Z; Kamdar K; Brouwers P
J Clin Oncol; 2008 Sep; 26(25):4138-43. PubMed ID: 18757327
[TBL] [Abstract][Full Text] [Related]
5. Facilitating care for childhood cancer survivors: integrating children's oncology group long-term follow-up guidelines and health links in clinical practice.
Eshelman D; Landier W; Sweeney T; Hester AL; Forte K; Darling J; Hudson MM
J Pediatr Oncol Nurs; 2004; 21(5):271-80. PubMed ID: 15381795
[TBL] [Abstract][Full Text] [Related]
6. Monitoring for cardiovascular disease in survivors of childhood cancer: report from the Cardiovascular Disease Task Force of the Children's Oncology Group.
Shankar SM; Marina N; Hudson MM; Hodgson DC; Adams MJ; Landier W; Bhatia S; Meeske K; Chen MH; Kinahan KE; Steinberger J; Rosenthal D;
Pediatrics; 2008 Feb; 121(2):e387-96. PubMed ID: 18187811
[TBL] [Abstract][Full Text] [Related]
7. Primary care of adult survivors of childhood cancer.
Seehusen DA; Baird D; Bode D
Am Fam Physician; 2010 May; 81(10):1250-5. PubMed ID: 20507049
[TBL] [Abstract][Full Text] [Related]
8. Long-term follow-up of pediatric cancer survivors: education, surveillance, and screening.
Landier W; Wallace WH; Hudson MM
Pediatr Blood Cancer; 2006 Feb; 46(2):149-58. PubMed ID: 16369924
[TBL] [Abstract][Full Text] [Related]
9. Survey of long-term follow-up programs in the United States for survivors of childhood brain tumors.
Bowers DC; Adhikari S; El-Khashab YM; Gargan L; Oeffinger KC
Pediatr Blood Cancer; 2009 Dec; 53(7):1295-301. PubMed ID: 19688835
[TBL] [Abstract][Full Text] [Related]
10. Endocrine late effects of childhood cancer therapy: a report from the Children's Oncology Group.
Nandagopal R; Laverdière C; Mulrooney D; Hudson MM; Meacham L
Horm Res; 2008; 69(2):65-74. PubMed ID: 18059086
[TBL] [Abstract][Full Text] [Related]
11. [Changes of neurocognitive functions as result of cancer treatment in children and adolescents].
Vlcková I; Pavelková K; Kepák T; Pilát M; Bajciová V; Mazánek P; Sterba J; Jelínek M
Klin Onkol; 2008; 21(5):294-302. PubMed ID: 19202961
[TBL] [Abstract][Full Text] [Related]
12. Late effects in long-term survivors after treatment for childhood acute leukemia.
Haddy TB; Mosher RB; Reaman GH
Clin Pediatr (Phila); 2009 Jul; 48(6):601-8. PubMed ID: 19264722
[TBL] [Abstract][Full Text] [Related]
13. A quantitative meta-analysis of neurocognitive sequelae in survivors of pediatric brain tumors.
Robinson KE; Kuttesch JF; Champion JE; Andreotti CF; Hipp DW; Bettis A; Barnwell A; Compas BE
Pediatr Blood Cancer; 2010 Sep; 55(3):525-31. PubMed ID: 20658625
[TBL] [Abstract][Full Text] [Related]
14. Neurocognitive impairment in children treated for cancer: how do we measure cognitive outcomes?
Gross-King M; Booth-Jones M; Couluris M
J Pediatr Oncol Nurs; 2008; 25(4):227-32. PubMed ID: 18559886
[TBL] [Abstract][Full Text] [Related]
15. Clinical practice guidelines for the psychosocial care of cancer survivors: current status and future prospects.
Jacobsen PB
Cancer; 2009 Sep; 115(18 Suppl):4419-29. PubMed ID: 19731353
[TBL] [Abstract][Full Text] [Related]
16. The role of cognitive remediation in childhood cancer survivors experiencing neurocognitive late effects.
Spencer J
J Pediatr Oncol Nurs; 2006; 23(6):321-5. PubMed ID: 17035622
[TBL] [Abstract][Full Text] [Related]
17. Progressive neurocognitive impairment in young adult survivors of childhood acute lymphoblastic leukemia.
Harila MJ; Winqvist S; Lanning M; Bloigu R; Harila-Saari AH
Pediatr Blood Cancer; 2009 Aug; 53(2):156-61. PubMed ID: 19405135
[TBL] [Abstract][Full Text] [Related]
18. A questionnaire based review of long-term follow-up programs for survivors of childhood cancer in Canada.
Guilcher GM; Fitzgerald C; Pritchard S
Pediatr Blood Cancer; 2009 Jan; 52(1):113-5. PubMed ID: 18821577
[TBL] [Abstract][Full Text] [Related]
19. Developmental perspectives on optimizing educational and vocational outcomes in child and adult survivors of cancer.
Rey-Casserly C; Meadows ME
Dev Disabil Res Rev; 2008; 14(3):243-50. PubMed ID: 18924156
[TBL] [Abstract][Full Text] [Related]
20. A model for care across the cancer continuum.
Hudson MM
Cancer; 2005 Dec; 104(11 Suppl):2638-42. PubMed ID: 16258932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
